STIM1 for stimulation of phagocyte NADPH oxidase -----------------------------------------------------------------------------------------------------
The increased susceptibility can be attributed to diminished neutrophil superoxide production, because phagocytosis and neutrophil infiltration are minimally altered while neutrophil NADPH oxidase activation is abrogated. These findings are consistent with a previous report on the involvement of STIM1 in NADPH oxidase activation using neutrophil-like HL-60 cells. 4 The study by
Zhang et al further demonstrates that SOCE is defective in Stim1 2/2 neutrophils activated through chemoattractant receptors as well as Fcg receptors and integrins. These receptors are activated in different manners, but they all stimulate IP 3 production that leads to SOCE (see figure) . Zhang et al also show that sustained increase in cytosolic Ca 21 concentration is required for neutrophil superoxide production primarily because of the role of calcium in the activation of the classical protein kinase C (PKC) isoforms (PKCa and PKCb in neutrophils). For Production of oxygen radicals is a major bactericidal function of phagocytes. However, it is a double-edged sword because of its tissuedamaging property. Zhang et al show that the Stim1 2/2 chimeras are resistant to ischemia/ reperfusion injury to the liver, suggesting that neutrophil production of oxygen radicals might contribute to the pathological changes in wild-type subjects. Future work using granulocyte-specific deletion of Stim1 will be helpful to ascertain the respective contribution of different blood cells to the observed changes. These studies create new opportunities for therapeutic intervention that targets STIM1. Conflict-of-interest disclosure: The author declares no competing financial interests. n CLLonal selection: survival of the fittest?
In this issue of Blood, Rossi et al provide further evidence for clonal evolution in chronic lymphocytic leukemia (CLL) and demonstrate the clinical importance of small TP53-deleted subclones detected at diagnosis in determining the natural history of the disease. 1 T he basic principle of Darwinian evolutionary theory is the natural selection of the fittest variants. Fitness is defined by the ability to survive and reproduce and the "fittest" as those best adapted to achieve this. This concept of subclonal selection of the "fittest" variants was first applied to cancer by Nowell in 1976 2 and has subsequently been supported by modern genomics. 3 Knowledge of the clonal diversity and clonal selection operating in any specific cancer is critical to the understanding of disease progression, response to treatment, and development of resistance. The clonal architecture of any cancer is in a constant state of evolutionary change, which can take place over prolonged periods. Clinically important mutations may be present at an early stage of the disease but only become evident over time through selective pressure. The clinical importance of chromosomal abnormalities in CLL has been recognized since the late 1990s. 4 Since then, more refined techniques such as fluorescence in situ hybridization (FISH) and Sanger sequencing
Clonal selection and expansion of TP53-mutated subclones during the clinical course of CLL. Yellow circles indicate the TP53-mutated CLL cell which expands through the disease course from below the level of conventional detection methods at diagnosis to become the dominant population in refractory disease. Blue circles indicate the non-TP53-mutated CLL cell which is the dominant clone at diagnosis but is subsequently replaced by the TP53-mutated subclone.
